Zobrazeno 1 - 10
of 62
pro vyhledávání: '"S K Nielsen"'
Autor:
Line Fuglsang Hansen, Nicholine S. K. Nielsen, Laura Cathrine Christoffersen, Christina Kruuse
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 8, Pp 1720-1729 (2021)
Abstract Remote ischemic conditioning (RIC) has well‐established cardioprotective effects in preclinical studies and promising results in preclinical stroke research. Effective translation from preclinical studies to clinical trials has yet to be a
Externí odkaz:
https://doaj.org/article/72785c63a00b4f46852b15fad5f1d704
Autor:
Heidi S. Eddelien, Jawad H. Butt, André C. Amtoft, Nicholine S. K. Nielsen, Emilie S. Jensen, Ida M. K. Danielsen, Thomas Christensen, Anne K. Danielsen, Nete Hornnes, Christina Kruuse
Publikováno v:
Brain and Behavior, Vol 11, Iss 8, Pp n/a-n/a (2021)
Abstract Objective Timely evaluation and initiation of treatment is the key for improving stroke outcomes, although minimizing the time from symptom onset to the first contact with healthcare professionals remains a challenge. We aimed to identify pa
Externí odkaz:
https://doaj.org/article/9b1fa616ab324ee29fabe25227247630
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 8, Iss 8, Pp 1720-1729 (2021)
Hansen, L F, Nielsen, N S K, Christoffersen, L C & Kruuse, C 2021, ' Translational challenges of remote ischemic conditioning in ischemic stroke-a systematic review ', Annals of Clinical and Translational Neurology, vol. 8, no. 8, pp. 1720-1729 . https://doi.org/10.1002/acn3.51405
Annals of Clinical and Translational Neurology, Vol 8, Iss 8, Pp 1720-1729 (2021)
Hansen, L F, Nielsen, N S K, Christoffersen, L C & Kruuse, C 2021, ' Translational challenges of remote ischemic conditioning in ischemic stroke-a systematic review ', Annals of Clinical and Translational Neurology, vol. 8, no. 8, pp. 1720-1729 . https://doi.org/10.1002/acn3.51405
Remote ischemic conditioning (RIC) has well‐established cardioprotective effects in preclinical studies and promising results in preclinical stroke research. Effective translation from preclinical studies to clinical trials has yet to be accomplish
Autor:
Emilie S. Jensen, Nete Hornnes, Ida M. K. Danielsen, Heidi Shil Eddelien, Thomas Christensen, Jawad H. Butt, Andre C. Amtoft, Anne Kjærgaard Danielsen, Nicholine S. K. Nielsen, Christina Kruuse
Publikováno v:
Brain and Behavior, Vol 11, Iss 8, Pp n/a-n/a (2021)
Eddelien, H S, Butt, J H, Amtoft, A C, Nielsen, N S K, Jensen, E S, Danielsen, I M K, Christensen, T, Danielsen, A K, Hornnes, N & Kruuse, C 2021, ' Patient-reported factors associated with early arrival for stroke treatment ', Brain and Behavior, vol. 11, no. 8, e2225 . https://doi.org/10.1002/brb3.2225
Brain and Behavior
Eddelien, H S, Butt, J H, Amtoft, A C, Nielsen, N S K, Jensen, E S, Danielsen, I M K, Christensen, T, Danielsen, A K, Hornnes, N & Kruuse, C 2021, ' Patient-reported factors associated with early arrival for stroke treatment ', Brain and Behavior, vol. 11, no. 8, e2225 . https://doi.org/10.1002/brb3.2225
Brain and Behavior
Objective Timely evaluation and initiation of treatment is the key for improving stroke outcomes, although minimizing the time from symptom onset to the first contact with healthcare professionals remains a challenge. We aimed to identify patient‐r
Autor:
Jawad H. Butt, Nicholine S. K. Nielsen, Nete Hornnes, Anne Kjærgaard Danielsen, Emilie S. Jensen, Heidi Shil Eddelien, Andre C. Amtoft, Christina Kruuse, Thomas Christensen, Ida M. K. Danielsen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd985725647e7f21e907315f7b6999d0
https://doi.org/10.1002/brb3.2225/v2/response1
https://doi.org/10.1002/brb3.2225/v2/response1
Publikováno v:
Lupus. 27(12)
Objective Preterm delivery for preeclampsia or placental insufficiency (PREPI) is a clinical criterion for antiphospholipid syndrome (APS), but no prior prospective studies have used the international classification criteria for APS. Our objective is
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 13:251-259
Androgen deprivation therapy (ADT) is used as first-line therapy for locally advanced or metastatic prostate cancer aiming to reduce testosterone to castrate levels. The authors present an overview of the existing cost-effectiveness studies of ADT in
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 13:261-270
Degarelix, approved in the USA in 2008, is a gonadotropin-releasing hormone antagonist, representing one of the latest additions to androgen deprivation therapy (ADT). ADT is used as first-line therapy for locally advanced or metastatic prostate canc
Autor:
Simon Travis, Chris Probert, Craig John Currie, Mark P. Connolly, S. K. Nielsen, Philippe Marteau
Publikováno v:
Journal of Crohn's and Colitis. 3:168-174
Introduction A previous randomised controlled trial has demonstrated that oral plus topical mesalazine enema is more effective than oral mesalazine alone for achieving clinical remission in mild-to-moderately active extensive ulcerative colitis (UC).
Publikováno v:
Value in Health. 11:A362-A659
OBJECTIVES: Alternative treatments are available to relieve people with moderate and severe psoriasis in states of remission and relapse. The purpose of this study was characterise treatment satisfaction with alternative therapies in a survey across